Cargando…

Genetic validation of PfFKBP35 as an antimalarial drug target

Plasmodium falciparum accounts for the majority of over 600,000 malaria-associated deaths annually. Parasites resistant to nearly all antimalarials have emerged and the need for drugs with alternative modes of action is thus undoubted. The FK506-binding protein PfFKBP35 has gained attention as a pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thommen, Basil T, Dziekan, Jerzy M, Achcar, Fiona, Tjia, Seth, Passecker, Armin, Buczak, Katarzyna, Gumpp, Christin, Schmidt, Alexander, Rottmann, Matthias, Grüring, Christof, Marti, Matthias, Bozdech, Zbynek, Brancucci, Nicolas MB
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2023
Materias:	Microbiology and Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629825/ https://www.ncbi.nlm.nih.gov/pubmed/37934560 http://dx.doi.org/10.7554/eLife.86975

Ejemplares similares

Revisiting the Effect of Pharmaceuticals on Transmission Stage Formation in the Malaria Parasite Plasmodium falciparum
por: Thommen, Basil T., et al.
Publicado: (2022)

New In Vitro Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial Combinations
por: Wicha, Sebastian G., et al.
Publicado: (2022)

On a mission to block transmission
por: Ross, Amanda, et al.
Publicado: (2018)

Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor
por: Rottmann, Matthias, et al.
Publicado: (2020)

Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment
por: Radohery, Georges F. R., et al.
Publicado: (2022)

Discovery of Small-Molecule Allosteric Inhibitors of PfATC as Antimalarials
por: Wang, Chao, et al.
Publicado: (2022)

Doxycycline has distinct apicoplast-specific mechanisms of antimalarial activity
por: Okada, Megan, et al.
Publicado: (2020)

Mechanistic insights into non-immunosuppressive immunophilin ligands as potential antimalarial therapeutics
por: Yoon, Ho Sup, et al.
Publicado: (2010)

Prospective surveillance study to detect antimalarial drug resistance, gene deletions of diagnostic relevance and genetic diversity of Plasmodium falciparum in Mozambique: protocol
por: Mayor, Alfredo, et al.
Publicado: (2022)

Efficacy of antimalarial herbal medicines used by communities in malaria affected regions globally: a protocol for systematic review and evidence and gap map
por: Ocan, Moses, et al.
Publicado: (2023)

Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques
por: Munigunti, Ranjith, et al.
Publicado: (2013)

Orthosteric–allosteric dual inhibitors of PfHT1 as selective antimalarial agents
por: Huang, Jian, et al.
Publicado: (2021)

Antibodies Targeting the PfRH1 Binding Domain Inhibit Invasion of Plasmodium falciparum Merozoites
por: Gao, Xiaohong, et al.
Publicado: (2008)

A Major Role for the Plasmodium falciparum ApiAP2 Protein PfSIP2 in Chromosome End Biology
por: Flueck, Christian, et al.
Publicado: (2010)

The effect of dose on the antimalarial efficacy of artesunate-mefloquine against Plasmodium falciparum malaria: a protocol for systematic review and individual patient data (IPD) meta-analysis
por: Mansoor, Rashid, et al.
Publicado: (2019)

Investigation of Heterochromatin Protein 1 Function in the Malaria Parasite Plasmodium falciparum Using a Conditional Domain Deletion and Swapping Approach
por: Bui, Hai T. N., et al.
Publicado: (2021)

Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
por: Ashton, Trent D., et al.
Publicado: (2023)

Search for the Active Ingredients from a 2‐Aminothiazole DMSO Stock Solution with Antimalarial Activity
por: Ropponen, Henni‐Karoliina, et al.
Publicado: (2021)

Plasmodium falciparum Eukaryotic Translation Initiation Factor 3 is Stabilized by Quinazoline-Quinoline Bisubstrate Inhibitors
por: Dobrescu, Irina, et al.
Publicado: (2023)

A heat-shock response regulated by the PfAP2-HS transcription factor protects human malaria parasites from febrile temperatures
por: Tintó-Font, Elisabet, et al.
Publicado: (2021)

Analysis of subtelomeric virulence gene families in Plasmodium falciparum by comparative transcriptional profiling
por: Witmer, Kathrin, et al.
Publicado: (2012)

Molecular approaches to malaria: on the way to integration
por: Bozdech, Zbynek
Publicado: (2004)

Ensemble modeling highlights importance of understanding parasite-host behavior in preclinical antimalarial drug development
por: Burgert, Lydia, et al.
Publicado: (2020)

Identification and Functional Validation of the Novel Antimalarial Resistance Locus PF10_0355 in Plasmodium falciparum
por: Van Tyne, Daria, et al.
Publicado: (2011)

Combined Transcriptome and Proteome Profiling for Role of pfEMP1 in Antimalarial Mechanism of Action of Dihydroartemisinin
por: Chen, Lina, et al.
Publicado: (2021)

Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway
por: Edgar, Rebecca CS, et al.
Publicado: (2022)

Full-length Plasmodium falciparum myosin A and essential light chain PfELC structures provide new anti-malarial targets
por: Moussaoui, Dihia, et al.
Publicado: (2020)

The catalytic subunit of Plasmodium falciparum casein kinase 2 is essential for gametocytogenesis
por: Hitz, Eva, et al.
Publicado: (2021)

Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials
por: Mahindra, Amit, et al.
Publicado: (2020)

A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparum gametocytemia in the controlled human malaria infection model
por: Reuling, Isaie J, et al.
Publicado: (2018)

Antioxidant defense in Plasmodium falciparum – data mining of the transcriptome
por: Bozdech, Zbynek, et al.
Publicado: (2004)

Data mining of the transcriptome of Plasmodium falciparum: the pentose phosphate pathway and ancillary processes
por: Bozdech, Zbynek, et al.
Publicado: (2005)

FKBP51 and FKBP12.6—Novel and tight interactors of Glomulin
por: Hähle, Andreas, et al.
Publicado: (2019)

Substrate-analogous inhibitors exert antimalarial action by targeting the Plasmodium lactate transporter PfFNT at nanomolar scale
por: Golldack, André, et al.
Publicado: (2017)

Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
por: Ross, Leila S., et al.
Publicado: (2018)

Plasmodium falciparum Thioredoxin Reductase (PfTrxR) and Its Role as a Target for New Antimalarial Discovery
por: McCarty, Sara E., et al.
Publicado: (2015)

Polyamidoamine Nanoparticles for the Oral Administration of Antimalarial Drugs
por: Martí Coma-Cros, Elisabet, et al.
Publicado: (2018)

Plasmodium falciparum adapts its investment into replication versus transmission according to the host environment
por: Abdi, Abdirahman I, et al.
Publicado: (2023)

Estimation of Excess Mortality in Germany During 2020-2022
por: Kuhbandner, Christof, et al.
Publicado: (2023)

Comparative Heterochromatin Profiling Reveals Conserved and Unique Epigenome Signatures Linked to Adaptation and Development of Malaria Parasites
por: Fraschka, Sabine A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_82126s0jdv3btvmn2tuh0nhre9